Cannabinoid receptor antagonists: a perspective

  • Mauro A.M. Carai
  • Carla Lobina
  • Gian Luigi Gessa
  • Giancarlo Colombo
Part of the Milestones in Drug Therapy MDT book series (MDT)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Iversen L (2003) Cannabis and the brain. Brain 126: 1252–1270PubMedCrossRefGoogle Scholar
  2. 2.
    Colombo G, Serra S, Brunetti G, Gomez R, Melis S, Vacca G, Carai MAM, Gessa GL (2002) Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology 159: 181–187PubMedCrossRefGoogle Scholar
  3. 3.
    Gallate JE, Saharov T, Mallet PE, McGregor IS (1999) Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370: 233–240PubMedCrossRefGoogle Scholar
  4. 4.
    Arnone M, Maruani J, Chaperon F, Thiébot M-E, Poncelet M, Soubrié P, Le Fur G (1997) Selective inhibition of sucrose and alcohol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132: 104–106PubMedCrossRefGoogle Scholar
  5. 5.
    Colombo G, Agabio R, Fà M, Guano L, Lobina C, Loche A, Reali R, Gessa GL (1998) Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR 141716. Alcohol Alcoholism 33: 126–130Google Scholar
  6. 6.
    Lallemand F, Soubrié PH, De Witte PH (2001) Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration. Alcohol Clin Exp Res 25: 1317–1323PubMedGoogle Scholar
  7. 7.
    Serra S, Carai MAM, Brunetti G, Gomez R, Melis S, Vacca G, Colombo G, Gessa GL (2001) The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behaviour in alcoholpreferring rats. Eur J Pharmacol 430: 369–371PubMedCrossRefGoogle Scholar
  8. 8.
    Freedland CS, Sharpe AL, Samson HH, Porrino LJ (2001) Effects of SR 1417161A on alcohol and sucrose self-administration. Alcohol Clin Exp Res 25: 277–282PubMedGoogle Scholar
  9. 9.
    Hungund BL, Basavarajappa BS, Vadasz C, Kunos G, Rodriguez de Fonseca F, Colombo G, Serra S, Parsons L, Koob GF (2002) Ethanol, endocannabinoids, and the cannabinoidergic signaling system. Alcohol Clin Exp Res 26: 565–574PubMedGoogle Scholar
  10. 10.
    Gallate JE, McGregor IS (1999) The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology 142: 302–308PubMedCrossRefGoogle Scholar
  11. 11.
    Colombo G, Vacca G, Serra S, Carai MAM, Gessa GL (2004) Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol’s motivational properties in alcohol-preferring rats. Eur J Pharmacol 498: 119–123PubMedCrossRefGoogle Scholar
  12. 12.
    Hungund BL, Szakall I, Adam A, Basavarajappa BS, Vadasz C (2003) Cannabinoid CB1 receptor knockout exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J Neurochem 84: 698–704PubMedCrossRefGoogle Scholar
  13. 13.
    Poncelet M, Maruani J, Calassi R, Soubrié P (2003) Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett 343: 216–218PubMedGoogle Scholar
  14. 14.
    Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci USA 100: 1393–1398PubMedGoogle Scholar
  15. 15.
    Naassila M, Pierrefiche O, Ledent C, Daoust M (2004) Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 46: 243–253PubMedCrossRefGoogle Scholar
  16. 16.
    Racz I, Bilkei-Gorzo A, Toth ZE, Michel K, Palkovits M, Zimmer A (2003) A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J Neurosci 23: 2453–2458PubMedGoogle Scholar
  17. 17.
    Boening JA-L, Lesch OM, Spanagel R, Wolffgramm J, Narita M, Sinclair D, Mason BJ, Wiesbeck GA (2001) Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials. Alcohol Clin Exp Res 25: 127S–131SPubMedGoogle Scholar
  18. 18.
    McBride WJ, Le A-D, Noronha A (2002) Central nervous system mechanisms in alcohol relapse. Alcohol Clin Exp Res 26: 280–286PubMedGoogle Scholar
  19. 19.
    Agabio R, Carai MAM, Lobina C, Pani M, Reali R, Vacca G, Gessa GL, Colombo G (2000) Development of short-lasting alcohol deprivation effect (ADE) in Sardinian alcohol-preferring rats. Alcohol 21: 59–62PubMedCrossRefGoogle Scholar
  20. 20.
    Serra S, Brunetti G, Vacca G, Lobina C, Carai MAM, Gessa GL, Colombo G (2003) Stable preference for high ethanol concentrations after alcohol deprivation in Sardinian alcohol-preferring (sP) rats. Alcohol 29: 101–108PubMedCrossRefGoogle Scholar
  21. 21.
    Serra S, Brunetti G, Pani M, Vacca G, Carai MAM, Gessa GL, Colombo G (2002) Blockade by the cannabinoid CB1 receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Eur J Pharmacol 443: 95–97PubMedCrossRefGoogle Scholar
  22. 22.
    Le Fur G, Arnone M, Rinaldi-Carmona M, Barth F, Heshmati H (2001) SR 141716, a selective antagonist of CB1 receptors and obesity. Abstract book, 2001 Meeting of the International Cannabinoid Research Society, San Lorenzo de El Escorial, Spain, 101Google Scholar
  23. 23.
    Kiefer F, Jahn H, Tarnasker T, Helwig H, Briken P, Holbach R, Kampf P, Stracke R, Baehr M, Naber D et al. (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism. A double-blind, placebo-controlled study. Arch Gen Psychiatry 60: 92–99PubMedCrossRefGoogle Scholar
  24. 24.
    Gallate JE, Mallet PE, McGregor IS (2004) Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats. Psychopharmacology 173: 210–216PubMedCrossRefGoogle Scholar
  25. 25.
    Vacca G, Serra S, Brunetti G, Carai MAM, Gessa GL, Colombo G (2002) Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB1 receptor antagonist, SR 141716. Eur J Pharmacol 445: 55–59PubMedCrossRefGoogle Scholar
  26. 26.
    Kirkham TC, Williams CM (2001) Synergistic effect of opioid and cannabinoid antagonists on food intake. Psychopharmacology 153: 267–270PubMedCrossRefGoogle Scholar
  27. 27.
    Rowland NE, Mukherjee M, Robertson K (2001) Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology 159: 111–116PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag/Switzerland 2005

Authors and Affiliations

  • Mauro A.M. Carai
    • 1
  • Carla Lobina
    • 1
  • Gian Luigi Gessa
    • 1
    • 2
  • Giancarlo Colombo
    • 1
  1. 1.Department of NeuroscienceUniversity of CagliariCagliariItaly
  2. 2.Section of CagliariC.N.R. Institute of NeuroscienceCagliariItaly

Personalised recommendations